These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4605833

  • 1. [Outcome in 64 chronic psychotics treated with delayed action Moditen or Modecate].
    Bastie Y.
    Ann Med Psychol (Paris); 1974 Apr; 1(4):531-6. PubMed ID: 4605833
    [No Abstract] [Full Text] [Related]

  • 2. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT, Hoerdt HP.
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of psychoses with a long-acting neuroleptic agent (fluphenazine decanoate). Clinico-psychopathological study of 53 patients].
    La Mura G, Specchio LM, Corfiati L, Porro V, Bertolino A.
    Acta Neurol (Napoli); 1974 Feb; 29(4):446-59. PubMed ID: 4615572
    [No Abstract] [Full Text] [Related]

  • 4. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F.
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluphenazine enanthate for the difficult psychotic patient.
    Stewart AR, Lavallee B.
    Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Fluphenazine enanthate, delayed-action neuroleptic dru utilizable in outpatients treatment of chronic psychosis].
    Lambert PA, Midenet M, Marcou G, Bouchardy M.
    J Med Lyon; 1967 Mar 05; 48(116):351-5. PubMed ID: 5614941
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Advantages and indications of Moditen-Retard].
    Vallade L.
    Encephale; 1970 Mar 05; ():Suppl:10-3. PubMed ID: 5458707
    [No Abstract] [Full Text] [Related]

  • 16. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
    Jouen F, Verité P, André D, Colonna L, Boucly P.
    Arzneimittelforschung; 1993 May 05; 43(5):509-11. PubMed ID: 8328993
    [Abstract] [Full Text] [Related]

  • 17. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].
    Richou H.
    Ann Med Psychol (Paris); 1975 Jul 05; 2(2):399-402. PubMed ID: 9894
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Results of therapy with Lyogen-Depot in schizophrenic diseases].
    Friemert K, Beier R, Vehreschild T.
    Psychiatr Neurol Med Psychol (Leipz); 1974 Jun 05; 26(6):374-7. PubMed ID: 4849639
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.